These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18081815)

  • 1. Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia.
    Sträter J; Wiesmüller C; Perner S; Kuefer R; Möller P
    Histopathology; 2008 Feb; 52(3):399-402. PubMed ID: 18081815
    [No Abstract]   [Full Text] [Related]  

  • 2. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
    Lee WA
    Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
    Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
    Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.
    Lisovsky M; Falkowski O; Bhuiya T
    Hum Pathol; 2006 Dec; 37(12):1601-6. PubMed ID: 16996568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus.
    Scheil-Bertram S; Lorenz D; Ell C; Sheremet E; Fisseler-Eckhoff A
    Mod Pathol; 2008 Aug; 21(8):961-7. PubMed ID: 18500268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
    Kunju LP; Chinnaiyan AM; Shah RB
    Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas.
    Cho EY; Kim KM; Park CK; Kim JJ; Sohn TS; Kim DW
    APMIS; 2007 Jun; 115(6):713-8. PubMed ID: 17550379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant expression of AMACR in many distinct tumour types.
    Went PT; Sauter G; Oberholzer M; Bubendorf L
    Pathology; 2006 Oct; 38(5):426-32. PubMed ID: 17008281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of alpha-methylacyl-CoA racemase (P504S) in sebaceous neoplasms.
    Halsey MA; Calder KB; Mathew R; Schlauder S; Morgan MB
    J Cutan Pathol; 2010 Apr; 37(4):446-51. PubMed ID: 19638170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How useful is alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in the differential diagnosis of kidney cancers?
    Szponar A; Beothe T; Kovacs G
    Histopathology; 2010 Jan; 56(2):263-5. PubMed ID: 20102405
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-methylacyl coenzyme A racemase is immunoreactive in extramammary Paget disease.
    Mayes DC; Patterson JW; Ramnani DM; Mills SE
    Am J Clin Pathol; 2007 Apr; 127(4):567-71. PubMed ID: 17369131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
    Skinnider BF; Oliva E; Young RH; Amin MB
    Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus.
    Shi XY; Bhagwandeen B; Leong AS
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):447-52. PubMed ID: 18665038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
    Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
    Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.